These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 37533223)

  • 1. Endoscopic management of upper urinary tract urothelial carcinoma.
    Park BH; Jeon SS
    Korean J Urol; 2013 Jul; 54(7):426-32. PubMed ID: 23878683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
    Gadzinski AJ; Roberts WW; Faerber GJ; Wolf JS
    J Urol; 2010 Jun; 183(6):2148-53. PubMed ID: 20399468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Management of Upper Tract Transitional Cell Carcinoma.
    Ordon M; Perlis N; Landman J
    Urol Pract; 2014 May; 1(1):22-26. PubMed ID: 37533223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic management of upper-tract urothelial carcinoma.
    Raman JD; Park R
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):545-554. PubMed ID: 28480774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
    Laukhtina E; Kawada T; Quhal F; Yanagisawa T; Rajwa P; von Deimling M; Pallauf M; Bianchi A; Majdoub M; Enikeev D; Fajkovic H; Teoh JY; Rouprêt M; Gontero P; Shariat SF
    Eur Urol Focus; 2023 Mar; 9(2):258-263. PubMed ID: 36428210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron-sparing Management of Upper Tract Urothelial Carcinoma.
    Suriano F; Brancato T
    Rev Urol; 2014; 16(1):21-8. PubMed ID: 24791152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.
    Ko YH
    Transl Cancer Res; 2020 Oct; 9(10):6589-6595. PubMed ID: 35117269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney sparing surgery for upper-tract urothelial carcinoma.
    Raman JD
    Minerva Urol Nefrol; 2016 Aug; 68(4):359-71. PubMed ID: 27058053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.
    Morriss S; Zargar H; Dias BH
    Urol J; 2021 Nov; 18(6):585-599. PubMed ID: 34746998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.